BACKGROUND: Bronchoscopic lung volume reduction (BLVR) using endobronchial valves (EBV) is an established therapy for advanced emphysema; however, real-world post-discharge outcomes remain incompletely characterized. RESEARCH QUESTION: What are the 30-day all-cause readmission rates, causes, and independent predictors of adverse outcomes after BLVR in a contemporary U.S. cohort? STUDY DESIGN AND METHODS: We queried the Nationwide Readmissions Database (NRD) from 2019-2022 to identify adult hospitalizations undergoing EBV placement on hospital day 0-1. Weighted analyses generated national estimates. Patients were stratified by 30-day readmission. Multivariable logistic regression identified independent predictors of readmission adjusting for demographics, comorbidities, and in-hospital complications. RESULTS: In total, 2,306 unweighted BLVR procedures were analyzed. The 30-day all-cause readmission rate was 9.8% (n = 226) and remained stable over time despite increasing procedural volume. Respiratory complications dominated readmissions: pneumothorax (25%), COPD exacerbation (24%), pneumonia (15%), and acute respiratory failure (6%). Independent predictors of readmission were pneumothorax during the index hospitalization (OR 1.69, 95% CI 1.12-2.56), and length of stay ≥ 6 days (OR 1.93, 95% CI 1.21-3.07). INTERPRETATION: Nearly one in ten patients with BLVR are readmitted within 30 days, predominantly for respiratory complications. Structured peri-discharge pathways targeting patients with index pneumothorax and those with higher-than-expected LOS may reduce early post-BLVR morbidity.
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.